Pharma reputation improves but still near bottom

Share this article:
Industry reputation, up 12 points in 2006 from its 2004 low, continues to languish near the bottom, alongside cable companies and car manufacturers but ahead of managed care and health insurance. The industry’s image rating crossed into the red in 2004 with a negative 4% net approval rating before clawing its way back into the black. Consecutive double-digit gains the last two years put the rating at a respectable positive 25% in 2006. Pollsters from Harris Interactive attribute the comeback to less unfavorable media coverage and publicity on such issues like drug prices, while bad publicity on drug safety problems does not seem to have had much impact. Reputation is still down from plus 60% in 1997.
Share this article:
You must be a registered member of MMM to post a comment.


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.